|
XRN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.032200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.435890E-02 |
| Normal-vs-Stage2 |
5.622200E-01 |
| Normal-vs-Stage3 |
5.661800E-02 |
| Normal-vs-Stage4 |
2.073000E-01 |
| Stage1-vs-Stage2 |
3.806600E-01 |
| Stage1-vs-Stage3 |
9.000000E-01 |
| Stage1-vs-Stage4 |
5.589000E-01 |
| Stage2-vs-Stage3 |
3.709800E-01 |
| Stage2-vs-Stage4 |
3.265800E-01 |
| Stage3-vs-Stage4 |
6.404600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.413800E-02 |
| Normal-vs-AfricanAmerican |
5.862300E-02 |
| Normal-vs-Asian |
1.352810E-01 |
| Caucasian-vs-AfricanAmerican |
8.799400E-01 |
| Caucasian-vs-Asian |
7.648000E-01 |
| AfricanAmerican-vs-Asian |
7.785200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.241600E-03 |
| Normal-vs-Female |
8.840600E-01 |
| Male-vs-Female |
2.042000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.317500E-02 |
| Normal-vs-Extreme_Weight |
3.764500E-03 |
| Normal-vs-Obese |
1.307770E-01 |
| Normal-vs-Extreme_Obese |
2.386600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.034000E-01 |
| Normal_Weight-vs-Obese |
4.336800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.699400E-01 |
| Extreme_Weight-vs-Obese |
1.633160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.557800E-01 |
| Obese-vs-Extreme_Obese |
5.826000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.627000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.527200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.962100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.458970E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.708800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.764300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.337700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.226030E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.111800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.176600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.284760E-01 |
| Normal-VS-Type2 PRCC |
5.51770000000174E-05 |
| Normal-VS-KIRP CIMP |
6.041000E-01 |
| Normal-VS-Unclassified PRCC |
9.189400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.843960E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.028400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.683200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.218800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.025800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.188600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.039520E-03 |
| Normal-vs-N1 |
3.960800E-01 |
| Normal-vs-N2 |
8.888800E-01 |
| N0-vs-N1 |
9.006500E-02 |
| N0-vs-N2 |
7.278600E-01 |
| N1-vs-N2 |
9.755600E-01 |
|
|
